1
Investors
About
Bioptamers develops personalized cancer therapies by using a microfluidic platform to select synthetic aptamer molecules that specifically target cancer cells and deliver therapeutic interventions.
Explore Bioptamers's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.